USPTO serial 75118177
ABGENIX
Reviewed by CopyMark Law Group
Reg. 2355509Status 710
- Filing date
- Status date
- Registration date
- Jun 6, 2000
- Examiner
- CHICOSKI, JENNIFER D
- Law office
- SCANNING ON DEMAND
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with ABGENIX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Foster City, CA
Foster City, CA
Foster City, CA
Foster City, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
BETH M. GOLDMAN
BETH M GOLDMAN HELLER EHRMAN WHITE & MCAULIFFE LLP333 BUSH STSAN FRANCISCO, CA 94104-2878UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | biochemicals, namely, monoclonal antibodies and fragments thereof for research and development, for general manufacturing and for use in the manufacture of pharmaceuticals; cell lines for research and development, for general manufacturing and for use in the manufacture of pharmaceuticals | SECTION 8 - CANCELLED | Dec 29, 1997 |
| 005 | pharmaceuticals, namely, monoclonal antibodies and fragments thereof for clinical, diagnostic and therapeutic use for the treatment of cancer, autoimmune diseases, infectious diseases, inflammatory diseases and genetic diseases; cell lines for clinical, diagnostic and therapeutic use for the treatment of cancer, autoimmune diseases, infectious diseases, inflammatory diseases and genetic diseases | SECTION 8 - CANCELLED | Dec 29, 1997 |
| 031 | animal embryos for laboratory use | SECTION 8 - CANCELLED | Dec 29, 1997 |
| 042 | pharmaceutical and biological product development consultation; and pharmaceutical and biological product development for others | SECTION 8 - CANCELLED | Dec 29, 1997 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ABGENIX, INC.
- Other trademarks owned by Cell Genesys, Inc.
- Other trademarks owned by ABGENIX, INC.
- Other trademarks owned by ABGENIX, INC.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 031
- Other trademarks in Class 042
- Similar marks named ABGENIX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 10, 2007 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Mar 28, 2006 | CFIT | CASE FILE IN TICRS | — |
| May 28, 2002 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 6, 2000 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 18, 2000 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 6, 1999 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Dec 3, 1999 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 13, 1999 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Oct 13, 1999 | IUAF | USE AMENDMENT FILED | — |
| Sep 7, 1999 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Sep 7, 1999 | EXT2 | SOU EXTENSION 2 FILED | — |
| Apr 6, 1999 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Mar 8, 1999 | EXT1 | SOU EXTENSION 1 FILED | — |
| Sep 8, 1998 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 16, 1998 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 15, 1998 | NPUB | NOTICE OF PUBLICATION | — |
| Apr 8, 1998 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 13, 1998 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 15, 1997 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 9, 1997 | ZZZY | PREVIOUS ACTION COUNT WITHDRAWN | — |
| Nov 21, 1996 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 7, 1996 | DOCK | ASSIGNED TO EXAMINER | — |